Abstract
Background: Breast cancer prevention with tamoxifen in high-risk women is limited due to concerns of endometrial cancer and thromboembolism. We report the risk of endometrial cancer, deep vein thrombosis and pulmonary embolism in women
Original language | English |
---|---|
Pages (from-to) | 318-328 |
Number of pages | 10 |
Journal | Cancer Treatment Reviews |
Volume | 38 |
Issue number | 4 |
DOIs | |
Publication status | Published - Jun 2012 |
Keywords
- Breast cancer
- Chemoprevention
- Deep vein thrombosis
- Endometrial cancer
- Pulmonary embolism
- Tamoxifen
- Young women